Table 1

Characteristics of study population (N = 178 patients)
Site All patients Men, n(%) Women, n(%) Clinical symptoms Main signs
N %
Pancreas 62 34.8 32(51.6) 30(48.4) Abdominal pain, Jaundice, Hypoglycaemia Jaundice
Rectum 36 20.2 29(80.6) 7(19.4) Gastrointestinal bleeding, Abdominal pain, Diarrhea Rectum mass
Somach 25 14.0 16(64.0) 9(36.0) Abdominal pain, Gastrointestinal bleeding, Dysphagia Abdominal tenderness
Duodenum 13 7.3 10(76.9) 3(23.1) Abdominal pain, Jaundice, Gastrointestinal bleeding Jaundice
Metastasis of unknown primary 12 6.7 6(50.0) 6(50.0) Abdominal pain, Asymptomatic, Fatigue Hepatomegaly
Esophagus 7 3.9 5(71.4) 2(28.6) Progressive dysphagia No signs
Appendix 6 3.4 2(33.3) 4(66.7) Abdominal pain, Abdominal distension Rebound pain in the Mcburney’s point
Jejunum/ileum 4 2.2 3(75.0) 1(25.0) Gastrointestinal bleeding, Small bowel obstruction Anemia
Gallbladder 4 2.2 1(25.0) 3(75.0) Jaundice, Asymptomatic Jaundice
Vater’s ampulla 3 1.7 3(100) 0(0) Jaundice, Abdominal pain, Jaundice
Peritoneum 3 1.7 0(0) 3(100) Abdominal pain, Asymptomatic Abdominal mass
Cecum 1 0.6 1(100) 0(0) Abdominal pain Abdominal mass
Choledoch 1 0.6 1(100) 0(0) Jaundice Jaundice
Greater omentum 1 0.6 0(0) 1(100) Asymptomatic No signs

Wang et al.

Wang et al. BMC Endocrine Disorders 2012 12:30   doi:10.1186/1472-6823-12-30

Open Data